Lesaffre acquires a majority interest in Envera
Lesaffre acquires a majority interest in Envera
Marcq-en-Baroeul, France and West Chester, PA, November 17, 2017:
As part of its ongoing expansion strategy in nutrition and health, Lesaffre, a global key player in the yeasts and fermentation industry today announces the acquisition of a majority interest in Envera, and innovative U.S. bioscience-based company.
Founded in 2004 by Michael L. Matheny, a long-time microbiologist entrepreneur and executive, Envera is a full solution provider in the field of microbiology. Based in West Chester, Pennsylvania, with experienced researchers, Envera develops specific microbial-based products for a range of applications.
With this transaction, Lesaffre will enhance its presence and product offering in the fast-growing nutritional ingredients and health sector. In July 2017, Lesaffre announced an investment in Intralytix, another U.S. biotechnology company and leader in bacteriophage technology.
Antoine Baule, Lesaffre’s Chief Executive Officer says: “Lesaffre welcomes this acquisition which is entirely in line with our strategic development objectives. We are pleased to contribute to Envera’s development and to build upon the skills and expertise of the team in place. The specific technology and the strains collection developed by the company will provide a substantial addition to our current portfolio.”
Paolo Rossi, President of Lesaffre’s Nutrition and Health activity, adds: “Envera’s impressive range of bacteria strains and products will enable us to widen our offering of microorganisms to our customers, especially in the field of human, animal, and plant care activity. What’s unique about Envera is its experience in the isolation, selection, production, and formulation of microbial cultures.”
Michael L. Matheny, President of Envera comments: “I am delighted to have partnered with Lesaffre, a French family company known and recognized internationally for its expertise and professionalism in fermentation. I am confident the synergies between our companies, coupled with Lesaffre’s resources and connections around the world, will enable Envera to significantly accelerate its growth.”
About Lesaffre As a key global player in yeasts and fermentation, Lesaffre designs, manufactures and markets innovative solutions for baking, food taste and pleasure, healthcare, and biotechnology. A family group founded in northern France in 1853 and now a multi-national and a multicultural company, Lesaffre is committed to working with confidence to better nourish and protect the planet. In close collaboration with its clients and partners, Lesaffre employs 9,500 people in more than 70 subsidiaries, based in about 40 countries. Lesaffre has global revenues of more than 1.9 billion euros, over 40 percent of which are in in emerging markets.
More information: www.lesaffre.com